88 related articles for article (PubMed ID: 9661882)
1. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.
Pasche B; Luo Y; Rao PH; Nimer SD; Dmitrovsky E; Caron P; Luzzatto L; Offit K; Cordon-Cardo C; Renault B; Satagopan JM; Murty VV; Massagué J
Cancer Res; 1998 Jul; 58(13):2727-32. PubMed ID: 9661882
[TBL] [Abstract][Full Text] [Related]
2. TbetaR-I(6A) is a candidate tumor susceptibility allele.
Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
[TBL] [Abstract][Full Text] [Related]
3. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
Park B; Jang JS; Park K
Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
[TBL] [Abstract][Full Text] [Related]
4. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
van Tilborg AA; de Vries A; Zwarthoff EC
J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
Chen T; Carter D; Garrigue-Antar L; Reiss M
Cancer Res; 1998 Nov; 58(21):4805-10. PubMed ID: 9809982
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.
Spillman MA; Schildkraut JM; Halabi S; Moorman P; Calingaert B; Bentley RC; Marks JR; Murphy S; Berchuck A
Gynecol Oncol; 2005 May; 97(2):543-9. PubMed ID: 15863158
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
11. Redirection of B cell responsiveness by transforming growth factor beta receptor.
Roes J; Choi BK; Cazac BB
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
[TBL] [Abstract][Full Text] [Related]
15. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
Bernadt CT; Rizzino A
Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky.
Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ
Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
Wilder PJ; Bernadt CT; Kim JH; Rizzino A
Mol Reprod Dev; 2002 Nov; 63(3):282-90. PubMed ID: 12237943
[TBL] [Abstract][Full Text] [Related]
18. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
19. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
20. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]